Pfizer: Investigator-Sponsored Oncology Research Grants - quarterly deadlines


Pfizer Global Medical

UI Contact: 

In order to continue to provide an efficient and transparent review process for the Oncology Research Grants program, Pfizer announces the following application windows for 2022. Pfizer is committed to review all proposals and send out decision notifications by the notification deadlines below:

Submission Window

Notification Deadline*

Oct 9, 2021 – Jan 6, 2022

Feb 24, 2022

Jan 7 – Mar 31, 2022

May 26, 2022

Apr 1 – May 31, 2022

Jul 28, 2022

Jun 1 – Aug 31, 2022

Oct 27, 2022

Sep 1, 2022 – Jan 5, 2023

Mar 2, 2023

* Please note that all studies involving avelumab will not be part of this review schedule due to inter-company Alliance review process.

Important note for applicants: Please do not wait until the submission deadline to enter your request into the online portal. Plan to apply early to allow time for clarification questions and to ensure completeness.

Qualified researchers are invited to submit investigator-sponsored research (ISR) and General Research proposals, according to the guidance and instructions found on the Pfizer ISR portal at All proposals must be submitted via the ISR submission portal. An ISR proposal requesting Pfizer support (e.g., funding and/or drug supply) is not a guarantee of acceptance or approval of that proposal. Decisions on support for ISR and General Research submissions are made by the applicable Pfizer global review committee. A formal notification regarding the status of your application will be sent on or before the posted notification date.

Pfizer support will only be extended upon the execution of an agreement. For any questions, please send an email to A list of Oncology assets available for ISR proposals, including Areas of Interest, are available on